Free Trial

Colgate-Palmolive Company (NYSE:CL) Shares Purchased by Vontobel Holding Ltd.

Colgate-Palmolive logo with Consumer Staples background

Vontobel Holding Ltd. grew its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 13.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 517,079 shares of the company's stock after purchasing an additional 59,988 shares during the period. Vontobel Holding Ltd. owned approximately 0.06% of Colgate-Palmolive worth $48,450,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after acquiring an additional 450 shares during the period. Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive during the fourth quarter worth about $36,000. Proficio Capital Partners LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $186,000. Fisher Asset Management LLC boosted its holdings in Colgate-Palmolive by 17.9% in the 4th quarter. Fisher Asset Management LLC now owns 72,628 shares of the company's stock valued at $6,603,000 after purchasing an additional 11,005 shares during the last quarter. Finally, Bridges Investment Management Inc. grew its stake in shares of Colgate-Palmolive by 2.3% in the 4th quarter. Bridges Investment Management Inc. now owns 13,161 shares of the company's stock valued at $1,196,000 after buying an additional 299 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

CL has been the topic of a number of recent analyst reports. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Citigroup upped their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Finally, UBS Group lifted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $101.69.

Read Our Latest Analysis on CL

Colgate-Palmolive Stock Up 0.3%

Shares of Colgate-Palmolive stock traded up $0.32 during trading hours on Wednesday, reaching $92.36. 5,342,183 shares of the company were exchanged, compared to its average volume of 4,799,870. The firm has a market cap of $74.85 billion, a PE ratio of 26.09, a PEG ratio of 4.89 and a beta of 0.37. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. Colgate-Palmolive Company has a 1 year low of $85.32 and a 1 year high of $109.30. The stock's fifty day moving average is $90.71 and its 200 day moving average is $90.56.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.86 EPS. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.76%.

Colgate-Palmolive announced that its board has authorized a share buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines